A 12-week intermittent fasting program produced weight-loss benefits that were still visible a year later. Participants who ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

A new Medicare pilot program covers GLP-1 weight loss drugs for a flat $50 monthly copay — but only through 2027. Here's who ...

With the help of exercise, a better diet, a lot of determination, and a GLP-1 medication, Jeanne Erland lost 164 pounds over ...

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored health insurance may not foot the bill.

Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.

A new study found intermittent fasting helped adults with obesity lose weight about as well as calorie counting, while requiring less mental effort.

The federal government is now offering a selection of brand-name weight loss medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare ...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...